NHS National Generic Pharmaceuticals - Clozapine
NHS England · awarded 16 June 2025 · delivered in England
£1
Award value
£1
3
Suppliers
Recorded as a small or medium-sized business
31 Jul 2027
Runs until
from 1 Aug 2025
Who
| Buyer | NHS England Runcorn |
|---|---|
| Suppliers |
Britannia Pharmaceuticals Leyden Delta B.V. Mylan |
| Category | goods |
| Classification | Pharmaceutical products CPV 33600000 |
| Notice published | 16 July 2025 |
What it is for
NHS National Generic Pharmaceuticals - Clozapine Offer reference number: CM/PHG/22/5667 Period of framework agreement: 1st August 2025 to 31st July 2027, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
1 award on file, worth £1.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 16 Jun 2025 | NHS National Generic Pharmaceuticals - ClozapineEngland | NHS England | Leyden Delta B.V. +2 | £1 |